Physician profile
James C Walter
NPI 1184633208
$1,220.86
in general payments reported to CMS, 2019-2025
15 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $75.18 · 2021: $69.13 · 2022: $63.15 · 2023: $143 · 2024: $424 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Miach Orthopaedics, INC. | $175.90 | 2024 | |
| Pacira Therapeutics, INC. | $157.16 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $141.47 | 2024 | Iovera |
| Ferring Pharmaceuticals INC. | $140.79 | 2020-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $116.62 | 2020-2024 | Na, Monovisc, Orthovisc |
| Integra Lifesciences Corporation | $115.63 | 2019-2022 | |
| Pylant Medical | $100.69 | 2019-2025 | |
| Linvatec Corporation | $81.32 | 2023 | Biobrace 23mm |
| Integrity Orthopaedics, INC. | $61.39 | 2024 | Integrity Orthopaedics |
| Kowa Pharmaceuticals America, INC. | $30.07 | 2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $27.97 | 2025 | |
| Daiichi Sankyo INC. | $22.77 | 2019 | |
| Ermi LLC | $19.60 | 2019 | |
| Avanos Medical | $18.66 | 2023 | Trivisc Sodium Hyaluronate |
| Bioventus LLC | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.